25.07.2005
na podstawie: Efficacy and tolerability of the new antiepileptic drugs
I: Treatment of new onset epilepsy
II: Treatment of refractory epilepsy
Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society
J.A. French, M. Kanner, J. Bautista, B. Abou-Khalil, T. Browne, C.L. Harden, W.H. Theodore, C. Bazil, J. Stern, S.C. Schachter, D. Bergen, D. Hirtz, G.D. Montouris, M. Nespeca, B. Gidal, W.J. Marks Jr, W.R. Turk, J.H. Fisher, B. Bourgeois, A. Wilner, R.E. Faught Jr, R.C. Sachdeo, A. Beydoun, T.A. Glauser
Neurology, 2004; 62: 1252-1260, 1261-1273